BA.2.75 accounted for 84 national COVID-19 across 20 states as of Aug. 8, but that number has creeped up to 189 as of Aug. 22. The estimates come from a dashboard run by Raj Rajnarayanan, PhD, the assistant dean of research and an associate professor at Arkansas State University. The dashboard uses GISAID, a global data platform that follows viruses.
The number of BA.2.75 cases are too few to be published by the CDC as BA.5 makes up nearly 9 in every 10 national cases. Two other omicron subvariants, BA.4 and BA.4.6, together account for about 1 in every 10.
Health experts have said BA.2.75 is a “scariant” and the WHO has not deemed it a variant of concern. Helix, a lab that helps the CDC track variants, recently said BA.2.75 infections were “sporadic.”
Here are the most recent estimates on BA.2.75 infections by state and Washington, D.C.:
California — 34
New Jersey — 26
New York — 19
Washington — 17
Texas — 13
Illinois — 11
Arizona — 8
Ohio — 7
North Carolina — 7
Georgia — 7
Wisconsin — 5
Virginia — 5
Pennsylvania — 4
Nebraska — 3
Massachusetts — 3
Maryland — 3
Indiana — 3
Minnesota — 2
Michigan — 2
Kansas — 2
Iowa — 2
Missouri — 1
Hawaii — 1
District of Columbia — 1
Delaware — 1
Connecticut — 1
Colorado — 1
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
